Similarly, models of PD and AD show that overexpression of PRKN (by means of AAV, lentivirus, germline editing, or introduction of membrane permeable PRKN) reduces cellular pathology and protects against disease progression [518–522]. This evidence concerns the gene PRKN and Alzheimer disease.